Overall, as the lack of recognition and presentation of tumor antigens by immune cells contributes to tumor invasion and progression [25], these findings suggest that CREBBP mutations directly promote lymphomagenesis by controlling the antigen presentation and interferon signaling pathways (Fig. 1). This evidence concerns the gene CREBBP and neoplasm.